Schonfeld Strategic Advisors 13F: Cuts A Stake by $35M

Schonfeld Strategic Advisors significantly scaled back its holdings in Agilent Technologies, Inc. (NYSE: A) during the first quarter of 2026. According to the firm's latest Form 13F filing with the Securities and Exchange Commission, the fund unloaded 263,322 shares, reducing its total position by 66.47111537442099%. The transaction left Schonfeld with 132,823 shares of the laboratory equipment manufacturer.

Schonfeld Pivots From Agilent Shares

Schonfeld entered the quarter with 396145.0 shares of Agilent but decided to trim the position substantially. The fund's remaining 132,823 shares were valued at $17,511,383.83 at the end of the reporting period. Because 13F filings are backward-looking and released weeks after the quarter ends, they reflect holdings as of March 31, 2026, and might not represent Schonfeld's current investment strategy.

Schonfeld's aggressive reduction stands in contrast to several other institutional moves earlier in the year. For example, investment giant Vanguard initiated a massive new stake in Agilent with more than 14 million shares, while regional managers like Tidal Investments and Mercer Global Advisors also expanded their positions. However, Schonfeld is not the only fund taking chips off the table, as Jane Street Group also slashed its position in the diagnostics specialist by 93% during a similar timeframe.

Agilent Stock Performance and Valuation

On Saturday, Agilent shares were priced at $131.84. This price level is hovering just above the stock's 200-day moving average of $131.61, but sits well below its 52-week high of $163.75. Over the past year, the stock has traded as low as $108.35. At current prices, Agilent has a price-to-earnings (P/E) ratio of 31.940828, while its forward P/E ratio is a more modest 23.965015.

Recent Earnings

Agilent reported annual revenue of $7372000256.0, representing revenue growth of 0.081. The company has maintained healthy profitability with a net margin of 0.19533001 and a return on equity of 0.20971. Investors keeping track of the company's financial calendar can look forward to November 25, 2026, when Agilent is scheduled to release its next quarterly earnings report.

Agilent Dividend

Agilent continues to return capital to its shareholders through a regular dividend. The company pays an annual dividend rate of $1.02 per share, which yields 0.65% at current market prices. Agilent maintains a conservative payout ratio of 0.1998, meaning it distributes about 20% of its net income to fund these payments.

Analysts Set New Price Targets

Despite Schonfeld's selling, Wall Street analysts have maintained high expectations for the diagnostics specialist. On October 13, 2026, TD Cowen maintained its Buy rating on the stock and lifted its price target to $196.0 from $180.0. On the same day, Morgan Stanley kept its Overweight rating and boosted its target to $190.0. Earlier in the month, on October 7, 2026, Barclays maintained its Overweight rating and set a price target of $195.0. Overall, the consensus among 21 analysts is a buy, with an average target price of $175.43.

About Agilent Technologies

Agilent Technologies provides specialized laboratory instruments, software, consumables, and services to clinical diagnostics, life sciences, and applied chemical markets. The Santa Clara, California-based company was spun off from Hewlett-Packard in 1999 and has since grown into a major global supplier of chromatography and mass spectrometry systems.

What to Watch at Agilent Technologies, Inc.

As Agilent moves toward its late-November earnings release, investors will likely watch to see if other hedge funds follow Schonfeld's lead or if they align with the bullish targets set by major Wall Street research firms. Because regulatory filings represent a snapshot of the past, upcoming quarterly declarations will reveal whether Schonfeld continued to exit its position or decided to hold its remaining stake.